InvestorsHub Logo
Followers 6
Posts 1500
Boards Moderated 0
Alias Born 10/19/2018

Re: None

Saturday, 10/12/2019 2:39:39 PM

Saturday, October 12, 2019 2:39:39 PM

Post# of 6726
MEDIPHARM $LABS: 2019-2020 Shareholder Updates :
[color=red][/color]

- Q1/2019 - revenue of 22M

- Q2/2019 - revenue of 31.42M

- Q3/2019 - November 12, 2019
Pre market

- Capital Structure:

Fully diluted shares (as of May 10, 2019): 140M + ~potentially 15M from its latest bought deal.. So approximately ~155M

- Business model: wholesale(Private labelling + white labelling)/tolling

Sales/tolling agreements with - Supreme, Terrascend, Emerald Health, Indiva, JWCA, Cronos Group, Canopy Growth, & undisclosed licensed producer

More agreements to be announced

- Current capacity of 150,000kg - expected to complete expansion to 250,000kg by end of Q2/19 (hopefully to be announced soon this week)

- Cashed up


- has closed a credit agreement (the “Credit Facility”) with a top 5 Canadian Schedule 1 bank (the “Bank”) for an aggregate $38.7 million.

recently closed a $75M bought deal @$5.55 option to purchase additional shares up to $86M

Signed $20M in debt with schedule 1 Bank

Total cash $100M+

- Up list to TSX

- Global reach

Facility under construction in Australia (Expected to be completed in H2 2019) - 75,000 KG capacity expected for H2 2019 (November)

https://www.newcannabisventures.com/canadian-extraction-leader-medipharm-labs-announces-first-supply-partnerships-for-australian-subsidiary/


Facility in Australia will be the HUB to export extracts/finished products into Asia Pacific

Facility in Canada will be the HUB to export extracts/finished products into Europe

Awaiting EU GMP certification - expected H2 2019 ( in order to ship to the EU)

Recently completed its first export shipment into Australia to AusCann Group holdings (https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aLABS-2776284&symbol=LABS®ion=C) ;


- Building towards a pharmceutical company

Formed a Science Advisory Committee group;expert scientist, researchers, and medical professionals

Focused on Pharma-grade cannabis oil and concentrates

More information here: https://www.civilized.life/articles/how-medipharm-is-preparing-for-the-future-of-cannabis/ ;

- Slides:

https://d1io3yog0oux5.cloudfront.net/_0e3791d75c2e44476440cbd2788c3a11/medipharmlabs/db/357/2889/pdf/MediPharm+Labs+-+October+2019.pdf

https://stockdaymedia.com/cannabis/medipharm-labs-and-cronos-group-enter-private-label-contract-manufacturing-agreement/


https://m.benzinga.com/article/14480625?utm_referrer=https%3A%2F%2Fwww.google.com%2F&utm_source=https%3A%2F%2Fwww.google.com%2F